Spotlight

Researchers analyzed whether valbenazine’s impact on tardive dyskinesia symptoms varied between patients with schizophrenia versus bipolar disorder.

Patients and clinicians generally report suboptimal disease control at lower rates than those determined by Selecting Therapeutic Targets in IBD-II metrics.

Optimizing pain management strategies can help physicians better support patients with COPD in their journey towards improved health and well-being.

Authors of a recent review outlined barriers to tardive dyskinesia diagnosis and how neurologists and psychiatrists can collaborate to optimize care.

Among the landscape of HF, comorbidities such as anemia and iron deficiency have garnered attention for their potential impact on patient outcomes.

The following is a summary of “Effect of iron deficiency on RV function in acute decompensated...

Iron deficiency anemia is common in patients with Crohn’s disease and ulcerative colitis, but iron supplementation also could be an effective treatment.

Dr. Brockway reviews non-pharmacological interventions, such as physical therapy, for pain management in COPD.

Vitamin E has shown potential for targeting the underlying mechanisms of inflammatory bowel disease, but more research into its clinical application is needed.

Comorbidities complicate COPD management, but the underlying mechanisms driving both conditions present an opportunity for therapeutic advancements.

Only half of patients with metastatic castration-resistant prostate cancer were tested for HRR mutations, and PARP inhibitors were underused.

Dr. Eiry Roberts discusses why clinicians should avoid anticholinergics in patients with tardive...

The administration of ferric carboxymaltose in patients with decompensated acute HF and iron...

Due to the critical nature of acute HF (AHF), accurately gauging the risk for mortality may help...

Iron deficiency is a widely prevalent finding in patients with heart failure, observed on average...

Men with metastatic hormone-sensitive prostate cancer who experience baseline bone pain have worse survival outcomes despite treatment intensification.

Various sessions at the 2024 ASCO Genitourinary Cancers Symposium reviewed health care discrimination and disparities among patients with prostate cancer.

Researchers emphasized the importance of bone-protective agents in patients treated for metastatic castration-resistant prostate cancer.

Researchers found correlations between PSMA PET total tumor burden and survival in patients with high-volume metastatic hormone-sensitive prostate cancer.

The following is a summary of “Effectiveness of Aspirin on Major COPD Outcomes: A Prevalent...